Wall Street Bullish on Telix Pharmaceuticals (TLX), Here’s Why

​Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the Best All-Time Low Stocks to Invest In Now. Wall Street is bullish on Telix Pharmaceuticals Limited (NASDAQ:TLX) after the company released its full-year 2025 results on February 19. ​Recently, on February 23, John Hester from Bell Potter reiterated a Buy rating on the stock with a price target of AU$19. On the same day, David Bailey from Morgan Stanley also reiterated a Buy rating on the stock with a price target of AU$25.6. ​In fiscal 2025, the ...